Literature DB >> 12143352

Seizure-induced damage in the developing human: relevance of experimental models.

Gregory L Holmes1, Rustem Khazipov, Yehezkiel Ben-Ari.   

Abstract

A considerable amount of money and effort is spent every year investigating the effects of seizure on the developing rodent brain. A critical question is the relevance of these studies to children. The goal of this chapter is to review the relationship between seizures during early development and cognitive impairment in children and rodents. While the majority of children with epilepsy have normal cognitive development, a small group of children with frequent, recurrent seizures show progressive cognitive impairment. Likewise, in rodent models recurrent seizures during early development are associated with cognitive impairment and histological changes including mossy fiber sprouting and reduced neurogenesis. Status epilepticus is associated with a lower morbidity and mortality rate in children than in adults. Status epilepticus in rodent models is associated with less cell loss and cognitive impairment than in adults. While rodent studies can offer a great deal of insight into mechanisms of seizure-induced brain damage, they also have significant limitations. No animal models have yet been developed that mimic human epileptic syndromes, such as infantile spasms, Lennox-Gastaut syndrome, or the severe myoclonic epilepsies. In addition, rodent studies supply only crude measures of learning and memory. Disturbances of language or higher cortical functions such as visual or auditory processing cannot be tested in animal models.

Entities:  

Mesh:

Year:  2002        PMID: 12143352     DOI: 10.1016/S0079-6123(02)35030-1

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  14 in total

1.  Differential effects of AMPA receptor activation on survival and neurite integrity during neuronal development.

Authors:  M Chiara Manzini; Donald J Joseph; Amy B MacDermott; Carol A Mason
Journal:  Mol Cell Neurosci       Date:  2007-03-24       Impact factor: 4.314

Review 2.  Epileptogenesis in the immature brain: emerging mechanisms.

Authors:  Sanjay N Rakhade; Frances E Jensen
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

3.  "One swallow does not make a summer" ... or does it?

Authors:  Istvan Mody
Journal:  Epilepsy Curr       Date:  2008 May-Jun       Impact factor: 7.500

4.  Does acquired epileptogenesis in the immature brain require neuronal death.

Authors:  Tallie Z Baram; Frances E Jensen; Amy Brooks-Kayal
Journal:  Epilepsy Curr       Date:  2011-01       Impact factor: 7.500

5.  Low doses of domoic acid during postnatal development produce permanent changes in rat behaviour and hippocampal morphology.

Authors:  T A Doucette; P B Bernard; H Husum; M A Perry; C L Ryan; R A Tasker
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  Wrong-way chloride transport: is it a treatable cause of some intractable seizures?

Authors:  Kevin J Staley
Journal:  Epilepsy Curr       Date:  2006 Jul-Aug       Impact factor: 7.500

7.  Seizure-induced changes in place cell physiology: relationship to spatial memory.

Authors:  Xianzeng Liu; Robert U Muller; Li-Tung Huang; John L Kubie; Alexander Rotenberg; Bruno Rivard; Maria Roberta Cilio; Gregory L Holmes
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

8.  The brain, seizures and epilepsy throughout life: understanding a moving target.

Authors:  Tallie Z Baram
Journal:  Epilepsy Curr       Date:  2012-07       Impact factor: 7.500

9.  Enhanced mossy fiber sprouting and synapse formation in organotypic hippocampal cultures following transient domoic acid excitotoxicity.

Authors:  Anabel Pérez-Gómez; R Andrew Tasker
Journal:  Neurotox Res       Date:  2013-12-18       Impact factor: 3.911

Review 10.  The Epilepsy Spectrum: Targeting Future Research Challenges.

Authors:  Gregory L Holmes; Jeffrey L Noebels
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.